The efficacy and safety of denosumab, risedronate, alendronate and teriparatide to treat male osteoporosis: a systematic review and bayesian network meta-analysis.
Saved in:
| Title: | The efficacy and safety of denosumab, risedronate, alendronate and teriparatide to treat male osteoporosis: a systematic review and bayesian network meta-analysis. |
|---|---|
| Authors: | Chai SJ; The Third Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China., Yu T; The Second Hospital of Jilin University, Changchun, Hebei, China., Wang GR; The Third Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China., Sun FL; The Third Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China., Xue H; The Third Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China., Zhang Z; The Third Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China., Ran B; The Third Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China. |
| Source: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2025 Jun 19; Vol. 16, pp. 1579101. Date of Electronic Publication: 2025 Jun 19 (Print Publication: 2025). |
| Publication Type: | Journal Article; Systematic Review; Network Meta-Analysis |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-2392 |
|---|---|
| DOI: | 10.3389/fendo.2025.1579101 |
